COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 805: Articles 8041-8050  | Next

Effectiveness of ChAdOx1 nCoV-19 Corona Virus Vaccine (CovishieldTM) in preventing SARS-CoV2 infection, Chennai, Tamil Nadu, India, 2021
Murali, S., Sakthivel, M., P, K., Venkataswamy, V., Thangaraj, J. W. V., Shete, A., John, A., Arjun, J., C P, G. K., Yadav, P. D., Sahay, R., Majumdar, T., Dhudhmal, M., Sivalingam, A., D, S. R., D, A., R, V., M, M. M., A, S., M, P., G, E., C, P., S, D. P. V., M, P., P, E., Parasuraman, G., M, J., Narnaware, M. S., Bedi, G. S., Kaur, P., Murekhar, M. V.
10.1101/2022.04.15.22273859 — Posted: 2022-04-16
Can We Really Trust the Findings of the COVID-19 Research? Quality Assessment of Randomized Controlled Trials Published on COVID-19
Joshy, A. S., Thomas, C., Surendran, S., Undela, K.
10.1101/2022.04.15.22273881 — Posted: 2022-04-16
Introduction and Establishment of SARS-CoV-2 Gamma Variant in New York City in Early 2021
Vasylyeva, T. I., Fang, C. E., Su, M., Havens, J. L., Parker, E., Wang, J. C., Zeller, M., Yakovleva, A., Hassler, G. W., Chowdhury, M. A., Andersen, K. G., Hughes, S., Wertheim, J. O.
10.1101/2022.04.15.22273909 — Posted: 2022-04-16
Using a real-world network to model the tradeoff between stay-at-home restriction, vaccination, social distancing and working hours on COVID-19 dynamics.
Nashebi, R., Sari, M., Kotil, S.
10.1101/2022.04.15.22273449 — Posted: 2022-04-16
COVID-19 vaccine effectiveness against SARS-CoV-2 infection in the United States prior to the Delta and Omicron-associated surges: a retrospective cohort study of repeat blood donors
Grebe, E., Yu, E. A., Bravo, M. D., Welte, A., Bruhn, R. L., Stone, M., Green, V., Williamson, P. C., Feldstein, L. R., Jones, J. M., Busch, M. P., Custer, B.
10.1101/2022.04.15.22273412 — Posted: 2022-04-16
Making maternity and neonatal care personalised in the COVID-19 pandemic: results from the Babies Born Better Survey in the UK and the Netherlands
van den Berg, L. M. M., Akooji, N., Thomson, G., de Jonge, A., Balaam, M.-C., Topalidou, A., Downe, S., the ASPIRE COVID-19 research team
10.1101/2022.04.11.22273702 — Posted: 2022-04-16
The dynamic reproduction index: accurate determination from incidence and application for an early warning system
Conradt, R. N. J., Herminghaus, S.
10.1101/2022.04.11.22273599 — Posted: 2022-04-16
To mask, or not to mask, Alice and Bob's dating dilemma
Ma, Z., Zhang, Y.-P.
10.1101/2022.04.14.22273886 — Posted: 2022-04-16
COVID-19 in the Mexican Social Security Institute (IMSS) population. Prevalent symptoms
Juarez Flores, A., Ascencio Montiel, I. J., Gutierrez, J. P., Bertozzi, S. M., Borja Aburto, V. H., Olaiz Fernandez, G. A.
10.1101/2022.04.12.22273734 — Posted: 2022-04-16
COVID-19 and Curcumin: Using VOSviewer software to explore scientific landscape, A bibliometric analysis
Abd El Wahab, M. H.
10.1101/2022.04.10.22273674 — Posted: 2022-04-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).